- Home
- REPL vs ADTN Comparison
REPL vs ADTN Comparison
Compare REPL & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ADTN
- Stock Information
- Founded
- REPL 2015
- ADTN 1985
- Country
- REPL United States
- ADTN United States
- Employees
- REPL N/A
- ADTN N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ADTN Telecommunications Equipment
- Sector
- REPL Health Care
- ADTN Telecommunications
- Exchange
- REPL Nasdaq
- ADTN Nasdaq
- Market Cap
- REPL 851.0M
- ADTN 831.1M
- IPO Year
- REPL 2018
- ADTN 1994
- Fundamental
- Price
- REPL $9.00
- ADTN $8.44
- Analyst Decision
- REPL Strong Buy
- ADTN Strong Buy
- Analyst Count
- REPL 6
- ADTN 4
- Target Price
- REPL $20.00
- ADTN $13.50
- AVG Volume (30 Days)
- REPL 658.1K
- ADTN 1.1M
- Earning Date
- REPL 05-15-2025
- ADTN 05-05-2025
- Dividend Yield
- REPL N/A
- ADTN N/A
- EPS Growth
- REPL N/A
- ADTN N/A
- EPS
- REPL N/A
- ADTN N/A
- Revenue
- REPL N/A
- ADTN $922,720,000.00
- Revenue This Year
- REPL $31.16
- ADTN $13.36
- Revenue Next Year
- REPL N/A
- ADTN $9.27
- P/E Ratio
- REPL N/A
- ADTN N/A
- Revenue Growth
- REPL N/A
- ADTN N/A
- 52 Week Low
- REPL $4.92
- ADTN $4.34
- 52 Week High
- REPL $17.00
- ADTN $12.44
- Technical
- Relative Strength Index (RSI)
- REPL 22.80
- ADTN 35.23
- Support Level
- REPL $10.17
- ADTN $8.76
- Resistance Level
- REPL $10.78
- ADTN $9.65
- Average True Range (ATR)
- REPL 0.62
- ADTN 0.33
- MACD
- REPL -0.19
- ADTN -0.01
- Stochastic Oscillator
- REPL 0.00
- ADTN 10.96
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.